Sensei biotherapeutics to participate in jefferies healthcare conference

Boston, may 25, 2022 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), an immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced that john celebi, president and chief executive officer, will present at the jefferies healthcare conference, being held in new york, ny and virtually, on wednesday, june 8, 2022 at 3:00 p.m. et.
SNSE Ratings Summary
SNSE Quant Ranking